Stryker Corporation $SYK Shares Purchased by Country Club Bank

Country Club Bank increased its holdings in shares of Stryker Corporation (NYSE:SYK) by 0.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,103 shares of the medical technology company’s stock after purchasing an additional 29 shares during the quarter. Country Club Bank’s holdings in Stryker were worth $2,402,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of SYK. Mogy Joel R Investment Counsel Inc. boosted its stake in shares of Stryker by 3.4% in the 1st quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company’s stock valued at $36,561,000 after buying an additional 3,218 shares during the period. Ferguson Wellman Capital Management Inc. boosted its stake in shares of Stryker by 1.9% in the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company’s stock valued at $65,096,000 after buying an additional 3,341 shares during the period. Harbor Capital Advisors Inc. purchased a new position in shares of Stryker in the 1st quarter valued at about $1,840,000. Mar Vista Investment Partners LLC boosted its stake in shares of Stryker by 10.2% in the 1st quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company’s stock valued at $33,572,000 after buying an additional 8,353 shares during the period. Finally, United Services Automobile Association purchased a new position in shares of Stryker in the 1st quarter valued at about $2,857,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Stryker

In other news, insider Viju Menon sold 500 shares of the company’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the sale, the insider directly owned 12,511 shares in the company, valued at $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the transaction, the director owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on SYK. Truist Financial set a $415.00 target price on Stryker and gave the stock a “hold” rating in a research note on Monday, August 4th. Weiss Ratings restated a “buy (b-)” rating on shares of Stryker in a research note on Saturday, September 27th. BTIG Research restated a “buy” rating on shares of Stryker in a research note on Monday, July 14th. Rothschild Redb upgraded Stryker to a “hold” rating in a research note on Thursday, September 18th. Finally, Wells Fargo & Company boosted their target price on Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Fifteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $430.10.

Stryker Trading Up 0.8%

Shares of SYK stock opened at $369.14 on Wednesday. The business’s fifty day moving average price is $381.50 and its 200 day moving average price is $378.86. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $406.19. The firm has a market capitalization of $141.12 billion, a PE ratio of 48.89, a P/E/G ratio of 2.64 and a beta of 0.94. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, topping analysts’ consensus estimates of $3.07 by $0.06. The company had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker’s quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, sell-side analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker’s dividend payout ratio is currently 44.50%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.